Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer.

Srivastava S.

Cancer Biomark. 2005;1(1):1-2. No abstract available.

PMID:
17192027
2.

Standards for validation of cancer biomarkers.

O'Connell CD, Atha DH, Jakupciak JP.

Cancer Biomark. 2005;1(4-5):233-9. Review.

PMID:
17192047
3.

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.

Kulasingam V, Diamandis EP.

Nat Clin Pract Oncol. 2008 Oct;5(10):588-99. doi: 10.1038/ncponc1187. Epub 2008 Aug 12. Review.

PMID:
18695711
4.

The cancer biomarker problem.

Sawyers CL.

Nature. 2008 Apr 3;452(7187):548-52. doi: 10.1038/nature06913. Review.

PMID:
18385728
5.

Thymidine kinase: diagnostic and prognostic potential.

O'Neill KL, Buckwalter MR, Murray BK.

Expert Rev Mol Diagn. 2001 Nov;1(4):428-33. Review.

PMID:
11901857
6.

Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.

Lin DW.

Urol Oncol. 2009 May-Jun;27(3):315-21. doi: 10.1016/j.urolonc.2009.01.026. Review.

PMID:
19414121
7.

Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.

Martin CM, Kehoe L, Spillane CO, O'Leary JJ.

Mol Diagn Ther. 2007;11(5):277-90. Review. Erratum in: Mol Diagn Ther. 2007;11(6):411.

PMID:
17963416
8.

Bladder cancer biomarkers: current developments and future implementation.

Alvarez A, Lokeshwar VB.

Curr Opin Urol. 2007 Sep;17(5):341-6. Review.

PMID:
17762628
9.

Biochemical and immunologic diagnosis of cancer. General cancer tests.

Laurence DJ.

Tumour Biol. 1987;8(2-3):75-7. Review. No abstract available.

PMID:
3329403
10.

Early detection and biomarkers in pancreatic cancer.

Misek DE, Patwa TH, Lubman DM, Simeone DM.

J Natl Compr Canc Netw. 2007 Nov;5(10):1034-41. Review.

PMID:
18053427
11.

Proteomic approaches in lung cancer biomarker development.

Cho JY, Sung HJ.

Expert Rev Proteomics. 2009 Feb;6(1):27-42. doi: 10.1586/14789450.6.1.27. Review.

PMID:
19210125
12.

PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment.

Kristensen LS, Hansen LL.

Clin Chem. 2009 Aug;55(8):1471-83. doi: 10.1373/clinchem.2008.121962. Epub 2009 Jun 11. Review.

13.

Skin cancer: new markers for better prevention.

Greinert R.

Pathobiology. 2009;76(2):64-81. doi: 10.1159/000201675. Epub 2009 Apr 9. Review.

PMID:
19367127
14.
16.
17.

The footprints of cancer development: Cancer biomarkers.

Ullah MF, Aatif M.

Cancer Treat Rev. 2009 May;35(3):193-200. doi: 10.1016/j.ctrv.2008.10.004. Epub 2008 Dec 4. Review.

PMID:
19062197
18.

DNA methylation markers: a versatile diagnostic tool for routine clinical use.

Lesche R, Eckhardt F.

Curr Opin Mol Ther. 2007 Jun;9(3):222-30. Review.

PMID:
17608020
19.

Personalized medicine for cancer: from molecular signature to therapeutic choice.

Sikora K.

Adv Cancer Res. 2007;96:345-69. Review. No abstract available.

PMID:
17161685
20.

How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.

Cordero OJ, De Chiara L, Lemos-González Y, Páez de la Cadena M, Rodríguez-Berrocal FJ.

Anticancer Res. 2008 Jul-Aug;28(4C):2333-41. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk